Before and after photos in UK clinic advertising: what the CAP Code requires

The Advertising Standards Authority reads a before and after photograph as a testimonial and a claim about efficacy at the same time. This guide sets out the proof a clinic has to hold before publishing, the rulings that define the standard, and where the United States rules part company.

Read article Use framework
Share this guide

Send it to someone working through the same question.

In short, MessagingUnited KingdomThe ASA treats a before and after photograph as a testimonial, so rules 3.47 to 3.50 apply.Branding Tatva · Insights
A thought to take into the work.

Start here

The direct answer

The Advertising Standards Authority treats before and after photographs in the same way as testimonials, so the CAP Code rules on testimonials apply. A clinic must hold signed and dated proof that each photograph is genuine and unmanipulated, must hold contact details for the person who supplied it, and must be able to substantiate the impression of efficacy the images create. Rules 3.47 to 3.50 carry those duties, and rule 3.7 requires the documentary evidence to be in hand before publication. Images of a medicine available only on prescription are very likely to breach rule 12.12, because that medicine may be advertised to the public only in restricted circumstances.

Link to the direct answer

Key takeaways

What to take from this article.

  • The ASA treats a before and after photograph as a testimonial, so rules 3.47 to 3.50 apply.
  • A clinic must hold signed and dated proof that each photograph is genuine and unmanipulated.
  • Rule 3.7 requires that documentary evidence before the advertisement is published, rather than after a complaint.
  • Images that exaggerate efficacy breach rule 3.11 even where the underlying treatment works.
  • Images of a medicine available only on prescription are very likely to breach rule 12.12.

Working framework · 5 decisions

The photograph file

Five items to hold for every before and after image before it reaches a website, a social post or a leaflet.

Decision 01 / 05

Name the person and record their consent

Rule 3.50 requires permission before a testimonial appears. Record who the patient is, what they agreed to, the date, and whether the consent covers a website, social media and print separately.
Read all 5 decisions
  1. Name the person and record their consent

    Rule 3.50 requires permission before a testimonial appears. Record who the patient is, what they agreed to, the date, and whether the consent covers a website, social media and print separately.

  2. Hold signed and dated proof

    The ASA expects signed and dated evidence that the photographs are genuine. A patient signature on a form describing the two images is what the rulings describe, rather than a folder of unlabelled files.

  3. Keep the untouched originals

    Retain the camera originals of both photographs with their timestamps, so retouching can be demonstrated rather than asserted if a question arrives.

  4. Write down what the images imply

    A photograph states a result. Record the claim the image makes about outcome, timescale and typicality, then check that the clinic holds evidence for that claim under rule 3.7.

  5. Check the treatment itself

    If the image shows a medicine available only on prescription, or a weight control intervention, a further prohibition applies above the testimonial rules.

Why a photograph is read as a testimonial

The Advertising Standards Authority's guidance on before and after photos, published in June 2025, states the position plainly: the Authority regards these photographs in the same way as testimonials. That classification is what turns an image into a documentary obligation.

Rule 3.47 requires a marketer to hold documentary evidence that a testimonial is genuine, together with contact details for the person who gave it. Rule 3.48 requires the testimonial to relate to the advertised product. Rule 3.49 requires any factual claim inside it to avoid misleading. Rule 3.50 requires permission before the testimonial is featured.

Rule 3.7 sits above those duties and sets the timing: documentary evidence has to be held before the marketing communication is distributed or submitted for publication. A clinic that assembles proof after a complaint has already failed the rule.

The signed and dated proof standard

The Authority has been specific about the form that evidence takes. In The Dental Suite ruling of 13 December 2017 and the EF Medispa ruling of 20 February 2013, the requirement described is signed and dated proof that the photographs are genuine and remain unmanipulated.

That standard is more demanding than it sounds. A clinic needs a record linking a named patient to an identified pair of images on an identified date, signed by that patient, plus a way to show the images stayed unaltered between capture and publication.

A folder of exported files with modified timestamps satisfies none of that. Neither does a screenshot of a message thread in which a patient says the treatment helped.

Exaggerating efficacy is a separate breach

Rule 3.11 prohibits misleading consumers by exaggerating the capability or performance of a product, and a photograph can breach that rule even where the treatment itself performs as claimed. The Authority has upheld complaints on exactly this ground.

In the Laser Treatment Clinic ruling of 22 August 2018, the advertiser confirmed that the before and after images were of people who were clients of the clinic and that the images indicated results a patient could expect. The Authority found the advertiser held no proof that the images were genuine and no evidence that they were representative of the effect a consumer could expect.

In the Smiles Powder UK ruling of 29 May 2019, on teeth whitening, the advertiser submitted clinical trials and customer testimonials. The Authority still concluded that the full body of evidence fell short of substantiating the claim that a perceptible whitening effect would be visible after one use.

The same guidance records the other outcome. Where an advertiser could substantiate the efficacy shown in the photographs, the Authority has declined to uphold, as in The Perfect Cosmetics Company ruling of 7 September 2016 and the L'Oréal (UK) ruling of 20 June 2018. The dividing line is evidence, rather than craft.

Prescription medicines: a prohibition above the testimonial rules

Rule 12.12 prohibits advertising a medicine available only on prescription to the public. The Authority's guidance addresses the photographic case directly: before and after imagery of such a medicine, even in isolation and without any accompanying claim, is very likely to be seen as an implied advertisement for that medicine, and therefore a breach.

For UK clinics this bears on any image showing the result of a botulinum toxin treatment. The guidance names Botox, Azzalure and Dysport in that context. An image captioned only with the clinic name still carries the implication the rule addresses.

The practical consequence is that consent, signed proof and substantiation resolve the testimonial question while leaving the prohibition untouched. A clinic can hold perfect evidence and still breach rule 12.12, because the evidence addresses the wrong question.

Weight control images carry an added duty

Where before and after images show a person who has followed a diet or exercise plan, the guidance adds a qualification: a clinic should avoid implying that it can treat obesity by showing a before image of an obese subject, unless the plan is supervised by a suitably qualified health professional.

Rule 12.2 sits behind that point, requiring marketers to avoid discouraging essential treatment for which medical supervision should be sought. The Authority's Pure Clear Minds ruling of 10 May 2023 upheld a complaint about a hypnotic gastric band programme that claimed a 95 per cent success rate with before and after images, where the evidence fell short.

Disclaimers close few gaps

The guidance is direct about qualifications. Superimposed text may clarify, and it cannot convert a misleading impression into a compliant one. Where the advertisement is inherently misleading, it remains so whatever qualification sits beneath it.

The guidance also removes a common assumption. Two photographs can mislead with no label at all, and an unlabelled pair is likely to be read as an implied efficacy claim.

Where the United States rules part company

A practice advertising in both markets faces two different tests for the same image, and the divergence is worth knowing because the United Kingdom standard is the stricter of the two on paperwork.

In the United States, the federal layer is the Federal Trade Commission's Endorsement Guides at 16 CFR Part 255. Section 255.1(g) addresses images specifically: using an endorsement with the image or likeness of a person other than the actual endorser is deceptive where it misrepresents a material attribute of the endorser.

The Commission's Example 6 puts the clinic problem in its own words. A page carrying accurate testimonials, accompanied by purchased stock photographs of people with near perfect skin rather than images of the actual endorsers, misrepresents the improvements to the endorsers' complexions. A second illustration finds a truthful testimonial accompanied by a photograph of somebody other than the actual endorser still capable of communicating a deceptive typicality claim.

The United States guidance addresses who appears in the image. The United Kingdom regime adds a documentary record, a permission requirement and, for prescription medicines, an outright prohibition. An image that satisfies the American standard can still fail the British one.

What to change on the website and the feed

Work through these in order. Each one closes a specific exposure named in the rules above.

  • Walk the published images on the website, social accounts and any leaflet, and count the pairs for which the clinic can produce signed and dated proof. Remove the rest until the file exists.
  • Check what each image implies about outcome and timescale, and confirm that the clinic holds evidence for that impression rather than only for the treatment in general.
  • Separate consent records from the marketing folder, and confirm each consent covers the channel the image appears in.
  • Review every image showing the result of a prescription medicine, and confirm whether it can be published at all under rule 12.12.
  • Look at images showing weight change, and check whether the plan they represent meets the supervised treatment condition.
  • Remove reliance on a caption disclaimer to rescue an image that makes an exaggerated claim on its own.

The limits of this guide

This is an interpretation of published regulatory guidance by a brand strategist. Read it alongside the Code and the guidance itself, and take legal questions to a solicitor.

It covers the CAP Code position for non broadcast advertising in the United Kingdom, plus the federal position in the United States. Professional regulators, such as the General Dental Council or the Health and Care Professions Council, add their own requirements in the United Kingdom, and a clinic should check the one that registers it.

The guidance and rulings cited were checked on 21 October 2026. The Authority updates its advice pages, and a fresh ruling can move the standard, so confirm the current text before relying on a specific paragraph.

Before you use it

Questions that can change the recommendation.

Can a UK clinic publish before and after photographs?

Yes, where the clinic holds signed and dated proof that the photographs are genuine and unmanipulated, holds permission from the patient, and can substantiate the impression of efficacy the images create. The Advertising Standards Authority treats the photographs as testimonials, so rules 3.47 to 3.50 apply.

Link to this answer
What proof does the ASA expect for a before and after image?

Signed and dated proof that the photographs are genuine, together with contact details for the person who supplied them. The ruling in The Dental Suite in December 2017 and EF Medispa in February 2013 describes that standard, and rule 3.7 requires the evidence to be held before publication rather than assembled after a complaint.

Link to this answer
Can a clinic publish before and after photos of Botox results?

The Authority's guidance states that before and after imagery of a medicine available only on prescription is very likely to be seen as an implied advertisement for that medicine, and therefore a breach of rule 12.12. That applies even where the image carries no accompanying claim.

Link to this answer
Does a disclaimer under the image make it acceptable?

Usually no. The guidance states that a qualification may clarify, and that it leaves an impression the advertisement creates untouched. An advertisement that misleads remains misleading whatever qualification sits beneath it.

Link to this answer
Does labelling matter if the images are obviously a pair?

The guidance is explicit that two photographs can mislead without a label, and an unlabelled pair is likely to be read as an implied efficacy claim.

Link to this answer
How do the US rules differ?

The Federal Trade Commission's Endorsement Guides at 16 CFR Part 255 govern the American position, and section 255.1(g) addresses images of somebody other than the actual endorser. The Commission's Example 6 treats stock photographs beside accurate testimonials as misrepresenting the results described. The United Kingdom regime adds a documentary record, a permission requirement and a prohibition on prescription medicine imagery.

Link to this answer

Research record

What this guide draws from.

Each source note describes what the reference supports. Platform guidance, research findings and Branding Tatva's practical suggestions have different scopes.

  1. Before and after photos (opens in a new tab)

    Advertising Standards Authority, AdviceOnline, 5 June 2025

    The Authority's position on before and after imagery, the testimonial classification, the signed and dated proof standard, the rulings it cites, and the prescription medicine and weight control qualifications.

  2. 03 Misleading advertising, UK Code of Non broadcast Advertising (opens in a new tab)

    Committee of Advertising Practice

    Rule 3.7 on holding documentary evidence before publication, rule 3.11 on exaggerating performance, and rules 3.47 to 3.50 on testimonials, consent and misleading factual claims.

  3. 16 CFR 255.1, General considerations (opens in a new tab)

    Electronic Code of Federal Regulations, Federal Trade Commission

    The United States position on image and likeness in endorsements, at section 255.1(g), and the Commission's Example 6 on stock photography beside testimonials.

  4. Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (opens in a new tab)

    Electronic Code of Federal Regulations

    The Guides as revised in 2023, source 88 FR 48102, 26 July 2023.